entacapone
Showing 1 - 25 of 65
Healthy Trial (Test (T) Entacapone,Levodopa and Carbidopa Tablets (II), Reference (R) Entacapone,Levodopa and Carbidopa Tablets
Not yet recruiting
- Healthy
- Test (T) Entacapone,Levodopa and Carbidopa Tablets (II)
- Reference (R) Entacapone,Levodopa and Carbidopa Tablets (II)
- (no location specified)
Jul 26, 2023
DESENSITIZE-PD: Intestinal Levodopa + Entacapone Therapy to
Not yet recruiting
- Parkinson Disease
- (no location specified)
Oct 14, 2022
Gastrointestinal Stromal Tumor, Malignant Trial in Changsha (Entacapone, Imatinib Mesylate)
Active, not recruiting
- Gastrointestinal Stromal Tumor, Malignant
- Entacapone
- Imatinib Mesylate
-
Changsha, Hunan, ChinaBin Li, MD
Nov 24, 2021
Parkinson Disease, Treatment Adherence Trial in Ankara (Levodopa)
Enrolling by invitation
- Parkinson Disease
- Treatment Adherence
-
Ankara, TurkeyAnkara Atatürk Sanatorium Training and Research Hospital
Oct 30, 2023
Tachycardia, Chronic Orthostatic Intolerance Trial in Nashville (drug, other, dietary supplement, radiation, procedure, device)
Active, not recruiting
- Tachycardia
- Chronic Orthostatic Intolerance
- Acetazolamide
- +22 more
-
Nashville, TennesseeVanderbilt University Autonomic Dysfunction Center
Sep 12, 2022
Autonomic Failure, Pure Autonomic Failure, Parkinson Disease Trial in Nashville ([18F]FDOPA, Carbidopa 200mg oral dose,
Recruiting
- Autonomic Failure
- +4 more
- [18F]FDOPA
- +2 more
-
Nashville, TennesseeVanderbilt University Medical Center
Apr 14, 2022
Parkinson Disease Trial (Stalevo, Carbidopa and Levodopa Controlled Release Tablets)
Not yet recruiting
- Parkinson Disease
- Stalevo
- Carbidopa and Levodopa Controlled Release Tablets
- (no location specified)
Jul 4, 2021
Gait Analysis in Neurological Disease
Active, not recruiting
- Parkinson's Disease
- +7 more
- Anti-Parkinson medication
- Deep Brain Stimulation
-
Boston, MassachusettsClinical Research Center BIDMC
Jul 20, 2021
Inhibiting COMT in Parkinson's Disease
Withdrawn
- Parkinson's Disease
-
Zurich, ZH, SwitzerlandUniversity Hospital Zurich, Division of Neurology
Jan 21, 2021
Methamphetamine Dependence Trial in Portland (Entacapone, Methamphetamine, Placebo)
Completed
- Methamphetamine Dependence
- Entacapone
- +2 more
-
Portland, OregonOregon Health & Science University
Sep 11, 2019
Parkinson Disease Trial in Rome (Standard LD/CD, Semi continuous intra-oral administration of LD/CD)
Completed
- Parkinson Disease
- Standard LD/CD
- Semi continuous intra-oral administration of LD/CD
-
Rome, ItalyIrccs San Raffaele Pisana
Oct 17, 2022
Parkinson Disease Trial in France (Surgery under general anesthesia with experimental targeting, Usual Surgery)
Recruiting
- Parkinson Disease
- Surgery under general anesthesia with experimental targeting
- Usual Surgery
-
Amiens, France
- +9 more
May 31, 2022
Cocaine Abuse Trial in New York (L-dopa / carbidopa / entacapone (LCE))
Completed
- Cocaine Abuse
- L-dopa / carbidopa / entacapone (LCE)
-
New York, New YorkNew York State Psychiatric Institute
May 17, 2018
Schizophrenia Trial run by the NIMH (Placebo, Tolcapone)
Terminated
- Schizophrenia
- Placebo
- Tolcapone
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 22, 2018
OCD Trial in Chicago (Tolcapone 200 MG)
Completed
- Obsessive-Compulsive Disorder
- Tolcapone 200 MG
-
Chicago, IllinoisUniversity of Chicago
Mar 16, 2022
Cocaine Dependence Trial in New York (levodopa carbidopa and entacapone (LCE), Placebo)
Completed
- Cocaine Dependence
- levodopa carbidopa and entacapone (LCE)
- Placebo
-
New York, New YorkSTARS
May 17, 2018
Parkinson's Disease Trial in East Hanover (Entacapone)
Completed
- Parkinson's Disease
- Entacapone
-
East Hanover, New JerseyNovartis Pharmaceuticals
Feb 21, 2017
Parkinson's Disease Trial in Worldwide (carbidopa, levodopa, entacapone)
Completed
- Parkinson's Disease
- carbidopa, levodopa, entacapone
-
Adelaide, Australia
- +17 more
Mar 27, 2017
Parkinson's Disease With Wearing-off Motor Fluctuations Trial in Dresden (BIA 9-1067, levodopa/dopa decarboxylase inhibitor)
Completed
- Parkinson's Disease With Wearing-off Motor Fluctuations
- BIA 9-1067
- levodopa/dopa decarboxylase inhibitor
-
Dresden, GermanyUniversity Hospital Carl Gustav Carus at the TU Dresden, Neurolo
Oct 12, 2018
Parkinson's Disease With End of Dose Wearing Off Trial in Puerto Rico, United States (Carbidopa/levodopa/entacapone)
Completed
- Parkinson's Disease With End of Dose Wearing Off
-
Phoenix, Arizona
- +41 more
Feb 28, 2017
Pituitary Adenoma Trial in Cardiff (PET imaging)
Unknown status
- Pituitary Adenoma
- PET imaging
-
Cardiff, United KingdomUniversity Hospital of Wales
Jan 24, 2019
Parkinson Disease Trial in S. Mamede do Coronado (Placebo, BIA 6-512, Madopar® 250)
Completed
- Parkinson Disease
- Placebo
- +3 more
-
S. Mamede do Coronado, PortugalHuman Pharmacology Unit (UFH) - BIAL - Portela & Cª, SA
Mar 29, 2017